Stoke Therapeutics (STOK) Expected to Announce Quarterly Earnings on Tuesday

Stoke Therapeutics (NASDAQ:STOK) is slated to report Q4 2025 earnings on Tuesday, March 17, 2026, with analysts forecasting $0.75 EPS and $5.32 million revenue. The firm’s shares opened at $38.31, market cap $2.19 billion, P/E 57.18, beta 1.07. Academy Sports & Outdoors (NASDAQ:ASO) will announce Q4 2026 results on the same day, projected $2.03 EPS and $1.7556 billion revenue.